aNPC for intervertebral disc degeneration

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 11 Sep 2025: Trial registered, NCT07168603
  2. 26 Sep 2025: Trial started, NCT07168603

The trials

NCT07168603: EvaluatIon of Autologous Nucleus Pulposus Cells (aNPC) in Degenerative Disc Disease

State
Under way
Phase
Phase 1 and Phase 2
People
12 planned
Started
26 Sep 2025
Primary completion
1 Dec 2026
Arms
aNPC will be injected into the degenerated disc to evaluate safety and efficacy
Results
None posted
  1. 11 Sep 2025: Trial registered
  2. 26 Sep 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.